The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Kirk, A. D., Burkly, L. C., Batty, D. S., Baumgartner, R. E., Berning, J. D., Buchanan, K., Fechner, J. H., Germond, R. L., Kampen, R. L., Patterson, N. B., et al. (1999) · Nature Medicine · doi:10.1038/9536 · Cited by 826
Hodivala-Dilke, K. M., McHugh, K. P., Tsakiris, D. A., Rayburn, H., Crowley, D., Ullman-Culleré, M., Ross, F. P., Coller, B. S., Teitelbaum, S., & Hynes, R. O. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5487 · Cited by 740
Self-citationThe CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
Kawai, T., Andrews, D., Colvin, R. B., Sachs, D. H., & Cosimi, A. B. (2000) · Nature Medicine · doi:10.1038/72162 · Cited by 692
P-selectin induces the expression of tissue factor on monocytes.
Celi, A., Pellegrini, G., Lorenzet, R., De Blasi, A., Ready, N., Furie, B. C., & Furie, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8767 · Cited by 590
A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
Denis, C., Methia, N., Frenette, P. S., Rayburn, H., Ullman-Culleré, M., Hynes, R. O., & Wagner, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9524 · Cited by 513
Self-citationAukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
Ni, H., Denis, C. V., Subbarao, S., Degen, J. L., Sato, T. N., Hynes, R. O., & Wagner, D. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9896 · Cited by 492
Self-citationLigands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa)
Du, X., Plow, E. F., Frelinger, A. L., O'Toole, T. E., Loftus, J. C., & Ginsberg, M. H. (1991) · Cell · doi:10.1016/0092-8674(91)90458-b · Cited by 486
Requirement for CD154 in the progression of atherosclerosis
Lutgens, E., Gorelik, L., Daemen, M. J. A. P., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., & Flavell, R. A. (1999) · Nature Medicine · doi:10.1038/15271 · Cited by 439
Scarborough, R. M., Naughton, M. A., Teng, W., Rose, J. W., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M., & Charo, I. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54042-4 · Cited by 375
Self-citationBarbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri
Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., Campbell, A. M., Nannizzi, L., & Charo, I. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92826-7 · Cited by 371
Self-citationInhibition of CD40 signaling limits evolution of established atherosclerosis in mice
Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356
Pro-coagulant state resulting from high levels of soluble P-selectin in blood
André, P., Hartwell, D., Hrachovinová, I., Saffaripour, S., & Wagner, D. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250475997 · Cited by 317
Self-citationAndré, P., Denis, C. V., Ware, J., Saffaripour, S., Hynes, R. O., Ruggeri, Z. M., & Wagner, D. D. (2000) · Blood · doi:10.1182/blood.v96.10.3322 · Cited by 308
Self-citationBoth early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Lutgens, E., Cleutjens, K. B. J. M., Heeneman, S., Koteliansky, V. E., Burkly, L. C., & Daemen, M. J. A. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7464 · Cited by 271
Primary immunodeficiency diseases. A molecular and genetic approach.
Shigeoka, A. O. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990903)86:1<92::aid-ajmg21>3.0.co;2-0 · Cited by 263
A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation
Graf, D., Müller, S., Korthäuer, U., van Kooten, C., Weise, C., & Kroczek, R. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250639 · Cited by 249
Role of Platelet P-Selectin and CD40 Ligand in the Induction of Monocytic Tissue Factor Expression
Lindmark, E., Tenno, T., & Siegbahn, A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2322 · Cited by 245
Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide
Charo, I. F., Nannizzi, L., Phillips, D. R., Hsu, M. A., & Scarborough, R. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52310-3 · Cited by 219
Self-citationMelter, M., Reinders, M. E. J., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., & Briscoe, D. M. (2000) · Blood · doi:10.1182/blood.v96.12.3801 · Cited by 197
An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin [see comments]
Lawler, J., & Hynes, R. (1989) · Blood · doi:10.1182/blood.v74.6.2022.2022 · Cited by 166
Self-citationMiller, D. L., Yaron, R., & Yellin, M. J. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.3.373 · Cited by 158
Pullen, S. S., Labadia, M. E., Ingraham, R. H., McWhirter, S. M., Everdeen, D. S., Alber, T., Crute, J. J., & Kehry, M. R. (1999) · Biochemistry · doi:10.1021/bi9909905 · Cited by 150
Cited by
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Ruggeri, Z. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1227 · Cited by 1,589
Takada, Y., Ye, X., & Simon, S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-215 · Cited by 1,205
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Metadata
- Authors
- André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D.
- Venue
- Nature Medicine
- Published
- 2002-03
- Volume
- 8
- Issue
- 3
- Pages
- 247-252
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2054540030
- Cited by
- 726
- References
- 31
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.